Compare ITIC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITIC | NAGE |
|---|---|---|
| Founded | 1972 | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Specialty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.1M | 350.8M |
| IPO Year | 1995 | N/A |
| Metric | ITIC | NAGE |
|---|---|---|
| Price | $233.80 | $4.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 15.3K | ★ 741.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.53% | N/A |
| EPS Growth | ★ 13.02 | N/A |
| EPS | ★ 18.57 | N/A |
| Revenue | ★ $272,755,000.00 | N/A |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ $12.56 | $21.29 |
| Revenue Growth | ★ 5.60 | N/A |
| 52 Week Low | $190.20 | $4.16 |
| 52 Week High | $288.98 | $14.66 |
| Indicator | ITIC | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 52.44 |
| Support Level | $230.57 | $4.73 |
| Resistance Level | $234.49 | $5.32 |
| Average True Range (ATR) | 5.74 | 0.16 |
| MACD | 2.19 | 0.06 |
| Stochastic Oscillator | 80.72 | 81.56 |
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.